Infection risk with JAK inhibitors in dermatoses: a meta‐analysisPatrick A. Ireland, John Sullivan, Deshan F. Sebaratnam et al.|International Journal of Dermatology|2024Cited by 27
Consensus on the Use of <scp>JAKinibs</scp> for Atopic Dermatitis in Australia and New Zealand. An <scp>eDelphi</scp> by the Australasian Medical Dermatology GroupMarius Rademaker, Li‐Chuen Wong, Harriet Kennedy et al.|Australasian Journal of Dermatology|2025Cited by 1